Amedisys Overview
- Year Founded
-
1982
- Status
-
Public
- Employees
-
19,000
- Stock Symbol
-
AMED
- Investments
-
62
- Share Price
-
$92.66
- (As of Wednesday Closing)
Amedisys General Information
Description
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Contact Information
Website
www.amedisys.comCorporate Office
- 3854 American Way
- Suite A
- Baton Rouge, LA 70816
- United States
Corporate Office
- 3854 American Way
- Suite A
- Baton Rouge, LA 70816
- United States
Amedisys Stock Performance
As of 12-Feb-2025, Amedisys’s stock price is $92.66. Its current market cap is $3.04B with 32.8M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $92.66 | $92.52 | $82.15 - $98.95 | $3.04B | 32.8M | 459K | $2.53 |
Amedisys Financials Summary
As of 30-Sep-2024, Amedisys has a trailing 12-month revenue of $2.32B.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 3,538,236 | 3,567,830 | 3,312,257 | 5,744,042 |
| Revenue | 2,321,060 | 2,236,382 | 2,223,199 | 2,214,112 |
| EBITDA | 219,994 | 91,527 | 207,294 | 360,972 |
| Net Income | 82,934 | (9,747) | 118,609 | 209,072 |
| Total Assets | 2,139,114 | 2,060,170 | 1,976,245 | 1,856,968 |
| Total Debt | 467,670 | 487,213 | 537,941 | 545,612 |
Amedisys Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Amedisys Comparisons
Industry
Financing
Details
Amedisys Competitors (41)
One of Amedisys’s 41 competitors is Enhabit (Health & Hospice Services), a Corporation company based in Dallas, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Enhabit (Health & Hospice Services) | Corporation | Dallas, TX | ||||
| Addus HomeCare | Formerly PE-Backed | Frisco, TX | ||||
| Encompass Health | Formerly VC-backed | Birmingham, AL | ||||
| National Healthcare | Corporation | Murfreesboro, TN | ||||
| Community Health Systems | Formerly PE-Backed | Franklin, TN |
Amedisys Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Amedisys Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Amedisys Investments & Acquisitions (62)
Amedisys’s most recent deal was a Corporate Asset Purchase with Amedisys (Regulatory Assets of Home Health Based in West Virginia) for . The deal was made on 20-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Amedisys (Regulatory Assets of Home Health Based in West Virginia) | 20-Jan-2023 | Corporate Asset Purchase | Buildings and Property | ||
| AssistedCare Home Health (Home Health Assets) | 01-Apr-2022 | Corporate Asset Purchase | Buildings and Property | ||
| Evolution Health (Health Care Services) | 01-Apr-2022 | Merger/Acquisition | Other Healthcare Services | ||
| connectRN | 08-Dec-2021 | Later Stage VC | Human Capital Services | ||
| Contessa | 01-Aug-2021 | Merger/Acquisition | Other Healthcare Services |
Amedisys ESG
Risk Overview
Risk Rating
Updated November, 15, 2024
21.86 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,120
Rank
Percentile
Healthcare
Industry
of 587
Rank
Percentile
Medical Services
Subindustry
of 102
Rank
Percentile
Amedisys Exits (3)
Amedisys’s most recent exit was on 01-May-2018 from East Tennessee Personal Care Service. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| East Tennessee Personal Care Service | 01-May-2018 | Completed |
|
||
| Associated Home Care | 01-Mar-2016 | Completed |
|
||
| Remedy Partners | 14-Jul-2014 | Early Stage VC | Completed |
|
Affiliates
Subsidiaries (14)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Asana Hospice Cleveland | Berea, OH | 2018 | |
| Missouri Hospice Holdings | Kansas City, MO | 2016 | |
| Contessa | Nashville, TN | 2015 | |
| Adventa Hospice | Baton Rouge, LA | 2007 | |
| Housecall Supportive Services | Baton Rouge, LA | 2007 |
Amedisys FAQs
-
When was Amedisys founded?
Amedisys was founded in 1982.
-
Where is Amedisys headquartered?
Amedisys is headquartered in Baton Rouge, LA.
-
What is the size of Amedisys?
Amedisys has 19,000 total employees.
-
What industry is Amedisys in?
Amedisys’s primary industry is Elder and Disabled Care.
-
Is Amedisys a private or public company?
Amedisys is a Public company.
-
What is Amedisys’s stock symbol?
The ticker symbol for Amedisys is AMED.
-
What is the current stock price of Amedisys?
As of 12-Feb-2025 the stock price of Amedisys is $92.66.
-
What is the current market cap of Amedisys?
The current market capitalization of Amedisys is $3.04B.
-
What is Amedisys’s current revenue?
The trailing twelve month revenue for Amedisys is $2.32B.
-
Who are Amedisys’s competitors?
Enhabit (Health & Hospice Services), Addus HomeCare, Encompass Health, National Healthcare, and Community Health Systems are some of the 41 competitors of Amedisys.
-
What is Amedisys’s annual earnings per share (EPS)?
Amedisys’s EPS for 12 months was $2.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
